NCT03233711 2026-03-18
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
5 trialsNCT01075633 2014-01-08
COLONFAM
Fundación Canaria Rafael Clavijo para la Investigación Biomédica
Phase 3 Completed
NCT01937429 2013-09-09
GRAND BLEU
Hospices Civils de Lyon
Phase 3 Unknown
NCT01251666 2012-09-03
HeMO
University Hospital, Caen
Phase 3 Completed
NCT01399710 2011-07-22
CAD-IMPACT
im3D S.p.A.
Phase 3 Completed